Sulprostone

Sulprostone

SCHEMBL94843

CS(=O)(=O)NC(=O)CCC/C=C/CC1C(=O)CC(O)C1/C=C/C(O)COc1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
THRB P10828 2/20 1.00
MEN1 O00255 1/20 1.00
KMT2A Q03164 1/20 1.00
PTGFR P43088 11/20 0.77
PTGER3 P43115 6/20 0.77
MGLL Q99685 1/20 0.56
TBXA2R P21731 4/20 0.55
PTGER1 P34995 3/20 0.55
PTGER2 P43116 3/20 0.52
PTGER4 P35408 2/20 0.52
PTGIR P43119 2/20 0.52
NR1I2 O75469 1/20 0.52
ESR1 P03372 1/20 0.52
PGR P06401 1/20 0.52
HPGD P15428 1/20 0.52
TSHR P16473 1/20 0.52
MAPK1 P28482 1/20 0.52
OPRK1 P41145 1/20 0.52
PDE4D Q08499 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulprostone SCHEMBL23352789 1.00 THRB (1.00) THRBMEN1KMT2APTGFRPTGER3
Sulprostone SCHEMBL15389929 1.00 THRB (1.00) THRBMEN1KMT2APTGFRPTGER3
Sulprostone SCHEMBL23352669 1.00 THRB (1.00) THRBMEN1KMT2APTGFRPTGER3
Sulprostone SCHEMBL23353043 1.00 THRB (1.00) THRBMEN1KMT2APTGFRPTGER3
Sulprostone SCHEMBL94842 1.00 THRB (1.00) THRBMEN1KMT2APTGFRPTGER3
Sulprostone SCHEMBL8682594 0.95 THRB (0.90) THRBMEN1KMT2APTGFRPTGER3
SCHEMBL11946647 0.88 THRB (0.78) THRBMEN1KMT2APTGFRPTGER3
SCHEMBL4303634 0.87 PTGFR (1.00) THRBMEN1KMT2APTGFRPTGER3
SCHEMBL4303639 0.87 PTGFR (1.00) THRBMEN1KMT2APTGFRPTGER3
Sulprostone SCHEMBL2557561 0.87 THRB (0.76) THRBMEN1KMT2APTGFRPTGER3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2166 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4608405-A1 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL Veradermics, Incorporated (US) 2025-09-03 EP claimed
EP-3895686-B1 NATURAL COMPOSITION FOR HAIR GROWTH STIMULATION AND HAIR LOSS PREVENTION AND TREATMENT FRAUNHOFER GES FORSCHUNG (DE) 2025-04-09 EP claimed
WO-2024091572-A1 COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL VERADERMICS INCORPORATED (US) 2024-05-02 WO claimed
US-20220401487-A1 COMPOSITIONS AND METHODS FOR IMMUNE CELL MODULATION IN ADOPTIVE IMMUNOTHERAPIES FATE THERAPEUTICS, INC. 2022-12-22 US claimed
US-11413309-B2 Compositions and methods for immune cell modulation in adoptive immunotherapies FATE THERAPEUTICS, INC. (US) 2022-08-16 US claimed
US-20220079915-A1 IMMUNOSUPPRESSIVE PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF SHANGHAI ARCHEUS BIOTECH CO., LTD. (CN) 2022-03-17 US claimed
EP-3903778-A1 IMMUNOSUPPRESSIVE PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF Shanghai Archeus Biotech Co., Ltd. (CN) 2021-11-03 EP claimed
WO-2021209442-A1 NATURAL COMPOSITION FOR HAIR GROWTH STIMULATION AND HAIR LOSS PREVENTION AND TREATMENT Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e. V. (DE) 2021-10-21 WO claimed
WO-2021209437-A1 NATURAL COMPOSITION FOR HAIR GROWTH STIMULATION AND HAIR LOSS PREVENTION AND TREATMENT WITHOUT PRESERVATIVES Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e. V. (DE) 2021-10-21 WO claimed
EP-3895686-A1 NATURAL COMPOSITION FOR HAIR GROWTH STIMULATION AND HAIR LOSS PREVENTION AND TREATMENT FRAUNHOFER-GESELLSCHAFT zur Förderung der angewandten Forschung e.V. (DE) 2021-10-20 EP claimed
US-5605922-A VISION DISORDERS; SIDE EFFECT REDUCTION ALCON LABORATORIES, INC. (US) 1997-02-25 US claimed
CN-1135178-A Treatment of uterine contractile disorders with nitric oxide synthase substrates and/or donors, or nitric oxide inhibitors SCHERING AG (DE) 1996-11-06 CN claimed
EP-0730448-A1 TREATMENT OF UTERINE CONTRACTILITY DISORDERS WITH A NITRIC OXIDE SYNTHASE SUBSTRATE AND/OR DONOR, OR A NITRIC OXIDE INHIBITOR SCHERING AKTIENGESELLSCHAFT (DE) 1996-09-11 EP claimed
WO-1996013267-A2 COMBINATIONS OF PROSTAGLANDINS AND BRIMONIDINE OR DERIVATIVES THEREOF FOR THE TREATMENT OF GLAUCOMA ALLERGAN (US) 1996-05-09 WO claimed
US-5480900-A Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma ALCON LABORATORIES, INC. (US) 1996-01-02 US claimed
EP-0664707-A1 COMBINATIONS OF PROSTAGLANDINS AND CLONIDINE DERIVATIVES FOR THE TREATMENT OF GLAUCOMA. ALCON LAB INC (US) 1995-08-02 EP claimed
WO-1995013802-A1 TREATMENT OF UTERINE CONTRACTILITY DISORDERS WITH A NITRIC OXIDE SYNTHASE SUBSTRATE AND/OR DONOR, OR A NITRIC OXIDE INHIBITOR SCHERING AKTIENGESELLSCHAFT (DE) 1995-05-26 WO claimed
WO-1994008585-A1 COMBINATIONS OF PROSTAGLANDINS AND CLONIDINE DERIVATIVES FOR THE TREATMENT OF GLAUCOMA ALCON LABORATORIES, INC. (US) 1994-04-28 WO claimed
EP-0179421-B1 ANTIGESTAGENS, GLUCOCORTICOIDS AND PROSTAGLANDINS FOR INDUCTION OF LABOUR OR INTERRUPTION OF PREGNANCY SCHERING AKTIENGESELLSCHAFT (DE) 1991-05-29 EP claimed
EP-0139608-B1 PROSTAGLANDINS AND ANTIGESTAGENS FOR THE ONSET OF LABOUR OR FOR THE INTERRUPTION OF PREGNANCY SCHERING AKTIENGESELLSCHAFT (DE) 1988-06-01 EP claimed